Literature DB >> 20530697

Targeting Wnt signaling: can we safely eradicate cancer stem cells?

Fumi Takahashi-Yanaga1, Michael Kahn.   

Abstract

The Wnt signaling pathways have been conserved throughout evolution and regulate cell proliferation, morphology, motility, and fate during embryonic development. These pathways also play important roles throughout adult life to maintain homeostasis of tissues including skin, blood, intestine, and brain by regulating somatic stem cells and their niches. Aberrant regulation of the Wnt pathway leads to neoplastic proliferation in these same tissues. It has been suggested that Wnt signaling is also involved in the regulation of cancer stem cells (CSC), because there are many similarities in the signaling pathways that regulate normal adult stem cells and CSC. In this Perspective, we have focused on the Wnt/beta-catenin signaling pathway, which is the most intensively studied and best characterized Wnt signaling pathway. We provide an overview on the function of the Wnt/beta-catenin signaling pathway in CSC, and the possibility of the development of novel therapeutics to target this pathway. (c) 2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20530697     DOI: 10.1158/1078-0432.CCR-09-2943

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  224 in total

Review 1.  Targeting Hedgehog--a cancer stem cell pathway.

Authors:  Akil A Merchant; William Matsui
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

2.  Controversies in cancer stem cells: targeting embryonic signaling pathways.

Authors:  Naoko Takebe; S Percy Ivy
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

Review 3.  The difficulty of targeting cancer stem cell niches.

Authors:  Mark A LaBarge
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

Review 4.  Head and neck cancer stem cells.

Authors:  S Krishnamurthy; J E Nör
Journal:  J Dent Res       Date:  2011-09-20       Impact factor: 6.116

Review 5.  Wnt/beta-catenin signaling in T-cell immunity and cancer immunotherapy.

Authors:  Luca Gattinoni; Yun Ji; Nicholas P Restifo
Journal:  Clin Cancer Res       Date:  2010-08-05       Impact factor: 12.531

Review 6.  Targeting Notch to target cancer stem cells.

Authors:  Antonio Pannuti; Kimberly Foreman; Paola Rizzo; Clodia Osipo; Todd Golde; Barbara Osborne; Lucio Miele
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

7.  T cell therapies-are T memory stem cells the answer?

Authors:  Jacqueline K Flynn; Paul R Gorry
Journal:  Ann Transl Med       Date:  2015-10

8.  Artemin stimulates radio- and chemo-resistance by promoting TWIST1-BCL-2-dependent cancer stem cell-like behavior in mammary carcinoma cells.

Authors:  Arindam Banerjee; PengXu Qian; Zheng-Sheng Wu; Xiaoge Ren; Michael Steiner; Nicola M Bougen; Suling Liu; Dong-Xu Liu; Tao Zhu; Peter E Lobie
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

9.  Anti-oncogenic activity of Chibby in the development of human nasopharyngeal carcinoma.

Authors:  Cheng-Fu Cai; Li-Man Liu; Han-Jing Shangguan; Cun-Shan Liu; Xian-Yang Luo; Yi-Meng Li
Journal:  Oncol Lett       Date:  2018-02-09       Impact factor: 2.967

10.  Identification and characterization of a novel small-molecule inhibitor of β-catenin signaling.

Authors:  Evan R Delgado; Jing Yang; Juhoon So; Stephanie Leimgruber; Michael Kahn; Tohru Ishitani; Donghun Shin; Gabriela Mustata Wilson; Satdarshan P Monga
Journal:  Am J Pathol       Date:  2014-05-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.